DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Resteghini C, Cavalieri S, Galbiati D. et al.
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated
and medullary thyroid cancer patients.
Best Pract Res Clin Endocrinol Metab 2017;
31: 349-361
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.